Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Hyperthyroidism I: Introduction

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...

Hyperthyroidism II: Pathophysiology

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...

Hypothyroidism II: Pathophysiology

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.

Synthesis and Regulation of Thyroid Hormones

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...

Graves Disease II: Pathophysiology

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Tumor-infiltrating lymphocytes display prognostic signatures associated with chemotherapy response in TNBC patients.

iScience·2026

Same author

Rare Ectopic Pregnancies, Cases, Confusions, and Clues.

Journal of clinical ultrasound : JCU·2026

Same author

Revisiting Ultrasound of Fetal Abdominal Cysts; the Common, the Uncommon and the Rare: A Pictorial Review.

Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine·2025

See all related articles

Search research articles

Related Experiment Video

Updated: May 14, 2026

Mixed Reality Assisted Radical Endoscopic Thyroidectomy

Mixed Reality Assisted Radical Endoscopic Thyroidectomy

Published on: January 31, 2025

Managing thyroid dysfunction in selected special situations.

Durr E Sabih¹, Mohammad Inayatullah

¹Multan Institute of Nuclear Medicine and Radiotherapy, Nishtar Hospital, Multan 60000, Pakistan. dsabih@yahoo.com.

Thyroid Research

|February 6, 2013

Summary

This summary is machine-generated.

Managing thyroid dysfunction involves normalizing hormone levels. This review focuses on complex cases with coexisting conditions, requiring careful adjustments to thyroid hormone therapy.

Related Experiment Videos

Last Updated: May 14, 2026

Mixed Reality Assisted Radical Endoscopic Thyroidectomy

Mixed Reality Assisted Radical Endoscopic Thyroidectomy

Published on: January 31, 2025

Area of Science:

Endocrinology
Internal Medicine

Background:

Thyroid dysfunction management typically aims to restore euthyroid hormone levels.
Treatment involves antithyroid drugs, radio-iodine, surgery for hyperthyroidism, or hormone replacement for hypothyroidism.

Purpose of the Study:

To review special situations and complexities in managing thyroid dysfunction.
To highlight the need for careful thyroid hormone level correction in patients with coexisting conditions.

Main Methods:

Literature review of complex thyroid dysfunction management.
Analysis of cases involving coexisting medical conditions.
Synthesis of current treatment strategies for special thyroid patient populations.

Main Results:

Coexisting conditions significantly complicate thyroid dysfunction management.
Specific clinical scenarios require tailored approaches to hormone level correction.
Standard treatment protocols may need modification based on individual patient factors.

Conclusions:

Effective thyroid dysfunction management necessitates addressing coexisting conditions.
Personalized treatment strategies are crucial for optimizing outcomes in complex thyroid cases.
Further research into managing thyroid dysfunction alongside other diseases is warranted.